Does ENCORAFENIB Cause Haemoglobin decreased? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Haemoglobin decreased have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.4% of all adverse event reports for ENCORAFENIB.
36
Reports of Haemoglobin decreased with ENCORAFENIB
0.4%
of all ENCORAFENIB reports
4
Deaths
18
Hospitalizations
How Dangerous Is Haemoglobin decreased From ENCORAFENIB?
Of the 36 reports, 4 (11.1%) resulted in death, 18 (50.0%) required hospitalization.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENCORAFENIB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which ENCORAFENIB Alternatives Have Lower Haemoglobin decreased Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN